Showing results (1-10 of 57) with videos related to
Sort By:
Pageof 6
Current Stem Cell Research & Therapy|December 17, 2008
Aldehyde dehydrogenase as a marker for stem cellsJan S MorebDrug Discovery Today|September 27, 2014
Aldehyde dehydrogenases in cancer: an opportunity for biomarker and drug development?Klaus Pors, Jan S MorebTherapeutic Advances in Cardiovascular Disease|April 19, 2019
Cardiotoxicity due to targeted anticancer agents: a growing challengeChintan P Shah, Jan S MorebThe Annals of Pharmacotherapy|December 16, 2011
Severe neutropenia following a prolonged course of vancomycin that progressed to agranulocytosis with drug reexposureJennifer M Duff, Jan S Moreb, Firas MuwallaJournal of Clinical Medicine Research|May 15, 2013
Outcomes of salvage autologous versus allogeneic hematopoietic cell transplantation for relapsed multiple myeloma after initial autologous hematopoietic cell transplantationBaldeep Wirk, Michael Byrne, Yunfeng Dai, et al.The Breast Journal|May 12, 2001
High-Dose Chemotherapy with Autologous Stem Cell Rescue as a Treatment Modality for Breast CancerJohn R. Wingard, Jan S. Moreb, Rebecca I. GaaCancer Chemotherapy and Pharmacology|December 13, 2016
Use of retinoic acid/aldehyde dehydrogenase pathway as potential targeted therapy against cancer stem cellsJan S Moreb, Deniz A Ucar-Bilyeu, Abdullah KhanClinical Transplantation|January 31, 2020
Postautologous stem cell transplantation engraftment syndrome: Improved treatment and outcomesZiyang Liu, Shuyao Zhang, Biljana Horn, et al.Critical Reviews in Oncology/Hematology|July 9, 2015
Immunotherapy for multiple myeloma: Current status and future directionsAyed O Ayed, Lung-Ji Chang, Jan S MorebCytometry. Part B, Clinical Cytometry|November 18, 2006
Heterogeneity of aldehyde dehydrogenase expression in lung cancer cell lines is revealed by Aldefluor flow cytometry-based assayJan S Moreb, James R Zucali, Blanca Ostmark, et al.Pageof 6